Ourania Tatsis Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Ourania Tatsis.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Ourania Tatsis. Ourania Tatsis is EVP, Chief Reg. & Quality Off. in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and EVP, Chief Regulatory Officer in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and SVP, CRO in VERTEX PHARMACEUTICALS INC / MA ($VRTX).
Latest Insider Trading Transactions of Ourania Tatsis
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 19 2021 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Reg. & Q ... | Payment of Exercise | F | 211.75 | 2,000 | 423,500 | 32,468 | 34.5 K to 32.5 K (-5.80 %) |
Feb 12 2021 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Reg. & Q ... | Payment of Exercise | F | 214.16 | 1,230 | 263,417 | 34,468 | 35.7 K to 34.5 K (-3.45 %) |
Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Reg. & Q ... | Grant | A | 0.00 | 13,952 | 0 | 35,698 | 21.7 K to 35.7 K (+64.16 %) |
Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Reg. & Q ... | Grant | A | 0.00 | 6,194 | 0 | 21,746 | 15.6 K to 21.7 K (+39.83 %) |
Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Reg. & Q ... | Grant | A | 0.00 | 2,814 | 0 | 15,552 | 12.7 K to 15.6 K (+22.09 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 288.38 | 9 | 2,595 | 12,738 | 12.7 K to 12.7 K (-0.07 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 287.61 | 33 | 9,491 | 12,747 | 12.8 K to 12.7 K (-0.26 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 286.12 | 20 | 5,722 | 12,780 | 12.8 K to 12.8 K (-0.16 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 284.30 | 10 | 2,843 | 12,800 | 12.8 K to 12.8 K (-0.08 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 281.23 | 21 | 5,906 | 12,810 | 12.8 K to 12.8 K (-0.16 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 279.93 | 17 | 4,759 | 12,831 | 12.8 K to 12.8 K (-0.13 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 276.35 | 10 | 2,764 | 12,848 | 12.9 K to 12.8 K (-0.08 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Option Exercise | M | 155.57 | 407 | 63,317 | 2,854 | |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Option Exercise | M | 187.53 | 559 | 104,829 | 6,145 | |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 275.30 | 30 | 8,259 | 12,738 | 12.8 K to 12.7 K (-0.23 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 274.13 | 330 | 90,463 | 12,768 | 13.1 K to 12.8 K (-2.52 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 273.15 | 210 | 57,362 | 13,098 | 13.3 K to 13.1 K (-1.58 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 272.09 | 217 | 59,044 | 13,308 | 13.5 K to 13.3 K (-1.60 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 270.19 | 136 | 36,746 | 13,525 | 13.7 K to 13.5 K (-1.00 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 268.80 | 43 | 11,558 | 13,661 | 13.7 K to 13.7 K (-0.31 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Buy | M | 155.57 | 407 | 63,317 | 13,704 | 13.3 K to 13.7 K (+3.06 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Buy | M | 187.53 | 559 | 104,829 | 13,297 | 12.7 K to 13.3 K (+4.39 %) |
Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Sell | S | 237.81 | 240 | 57,074 | 12,738 | 13 K to 12.7 K (-1.85 %) |
Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Sell | S | 235.39 | 160 | 37,662 | 12,978 | 13.1 K to 13 K (-1.22 %) |
Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Sell | S | 234.43 | 240 | 56,263 | 13,138 | 13.4 K to 13.1 K (-1.79 %) |
Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Sell | S | 232.43 | 80 | 18,594 | 13,378 | 13.5 K to 13.4 K (-0.59 %) |
Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Sell | S | 231.82 | 160 | 37,091 | 13,458 | 13.6 K to 13.5 K (-1.17 %) |
Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Sell | S | 229.57 | 416 | 95,501 | 13,618 | 14 K to 13.6 K (-2.96 %) |
Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Payment of Exercise | F | 239.23 | 1,036 | 247,842 | 14,034 | 15.1 K to 14 K (-6.87 %) |
Feb 07 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Option Exercise | M | 155.57 | 408 | 63,473 | 3,261 | |
Feb 07 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Option Exercise | M | 187.53 | 559 | 104,829 | 6,704 | |
Feb 07 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Sell | S | 242.47 | 66 | 16,003 | 16,946 | 17 K to 16.9 K (-0.39 %) |
Feb 07 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Sell | S | 240.70 | 90 | 21,663 | 17,012 | 17.1 K to 17 K (-0.53 %) |
Feb 07 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Sell | S | 239.68 | 240 | 57,523 | 17,102 | 17.3 K to 17.1 K (-1.38 %) |
Feb 07 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Sell | S | 238.77 | 571 | 136,338 | 17,342 | 17.9 K to 17.3 K (-3.19 %) |
Feb 07 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Buy | M | 155.57 | 408 | 63,473 | 17,913 | 17.5 K to 17.9 K (+2.33 %) |
Feb 07 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Buy | M | 187.53 | 559 | 104,829 | 17,505 | 16.9 K to 17.5 K (+3.30 %) |
Feb 07 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Grant | A | 0.00 | 6,194 | 0 | 16,946 | 10.8 K to 16.9 K (+57.61 %) |
Feb 07 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Grant | A | 0.00 | 3,500 | 0 | 10,752 | 7.3 K to 10.8 K (+48.26 %) |
Jan 10 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Option Exercise | M | 187.53 | 1,675 | 314,113 | 7,263 | |
Jan 10 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Sell | S | 227.53 | 1,675 | 381,113 | 7,252 | 8.9 K to 7.3 K (-18.76 %) |
Jan 10 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Buy | M | 187.53 | 1,675 | 314,113 | 8,927 | 7.3 K to 8.9 K (+23.10 %) |
Nov 19 2019 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Sell | S | 205.95 | 5 | 1,030 | 7,252 | 7.3 K to 7.3 K (-0.07 %) |
Nov 15 2019 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Option Exercise | M | 155.57 | 2,853 | 443,841 | 3,669 | |
Nov 15 2019 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Sell | S | 205.59 | 2,853 | 586,548 | 7,252 | 10.1 K to 7.3 K (-28.23 %) |
Nov 15 2019 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Buy | M | 155.57 | 2,853 | 443,841 | 10,105 | 7.3 K to 10.1 K (+39.34 %) |
Oct 03 2019 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Sell | S | 167.69 | 444 | 74,454 | 7,252 | 7.7 K to 7.3 K (-5.77 %) |
Oct 03 2019 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Sell | S | 169.11 | 188 | 31,793 | 7,696 | 7.9 K to 7.7 K (-2.38 %) |
Page: 1